aap Implantate Second Quarter 2023 Earnings: €0.12 loss per share (vs €0.096 loss in 2Q 2022)

aap Implantate (ETR:AAQ1) Second Quarter 2023 Results

Key Financial Results

• Revenue: €3.11m (down 5.3% from 2Q 2022).
• Net loss: €1.03m (loss widened by 80% from 2Q 2022).
• €0.12 loss per share (further deteriorated from €0.096 loss in 2Q 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

aap Implantate Earnings Insights

Looking ahead, revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Medical Equipment industry in Germany.

Performance of the German Medical Equipment industry.

The company's shares are up 7.6% from a week ago.

Risk Analysis

Be aware that aap Implantate is showing 5 warning signs in our investment analysis and 4 of those are potentially serious...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.